Singapore Builds a Local Repository for PROMs Validation Across 35 Conditions
Singapore now has a consolidated repository of patient-reported outcome measures validated for local use, and the scale of the work is larger than a simple inventory. The scoping review identified 115 locally validated PROMs from 165 studies, creating a practical map for clinicians, researchers, and health systems trying to choose instruments that actually fit the population being measured. In a setting that increasingly uses patient-reported data to track symptom burden, function, and recovery, the value of a locally validated tool is straightforward: it reduces the risk of importing a questionnaire that performs well elsewhere but behaves differently in Singaporean patients.
The review followed PRISMA-ScR guidance and searched PubMed, Embase, Scopus, PsycINFO, Factiva, and ProQuest for studies published through 19 September 2024. Selected instruments were organized using COSMIN-based psychometric categories, including reliability, validity, responsiveness, and interpretability. That structure matters because PROMs are only clinically useful when their measurement properties are known in the target setting. A questionnaire that cannot demonstrate internal consistency, validity, or responsiveness can blur real change rather than capture it.
What the Repository Found in the Singapore Literature
Two instruments dominated the literature by study count: the EuroQol 5 Dimension questionnaire and the 36-Item Short Form Health Survey. Their prominence is unsurprising. Both are widely used generic health status measures, so they tend to appear in studies that need a broad quality-of-life framework rather than a disease-specific lens. Their repeated validation in Singapore suggests that researchers have relied on them as common currency for outcome measurement across diverse clinical contexts.
The repository spanned 35 conditions, with musculoskeletal diseases accounting for the largest share of locally validated PROMs. That concentration reflects a familiar clinical truth: chronic pain, mobility limitation, and function loss are areas where patient report often captures morbidity better than a single laboratory value or imaging result. In rheumatology, orthopedics, rehabilitation, and chronic pain care, patient perspective is often the outcome that matters most at the bedside.
A single sentence captures the practical gap in the literature: pneumonia, caesarean section, and hemorrhoidectomy lacked validated PROMs for Singapore. For those conditions, the absence is not a theoretical problem. It means clinicians and investigators may be measuring recovery, symptom relief, or postoperative burden with tools that have not been tested for local cultural, linguistic, and clinical relevance.
Reliability and Validity Dominated the Psychometric Work
Validity and reliability were the most frequently assessed measurement properties among the identified PROMs. That pattern suggests the Singapore literature has concentrated on the foundational question first: does the instrument measure what it is supposed to measure, and does it do so consistently? Internal consistency and measurement error fall under reliability, while content, criterion, and construct validity help determine whether the item set reflects the intended health domain and aligns with external standards or related constructs.
Responsiveness and interpretability were included in the review framework as well, but these properties are often harder to establish and easier to overlook. Responsiveness is clinically important because a measure that cannot detect improvement or deterioration has limited value in follow-up care, rehabilitation, or treatment evaluation. Interpretability is equally important at the bedside because clinicians need to know what a score means, not just whether it exists on a scale.
This is where local validation becomes more than a checklist exercise. A PROM may have strong international credentials and still miss language nuance, health beliefs, symptom expression, or cultural expectations specific to Singapore. A patient’s description of pain, fatigue, embarrassment, or functional limitation can shift in meaning depending on context, and those differences can alter how an item performs statistically and clinically.
Why Local Validation Changes Clinical Use
Validated PROMs are not interchangeable commodities. A measure designed for one population can overestimate or underestimate burden in another if response patterns differ, if item wording does not translate cleanly, or if the clinical context changes what patients consider important. In a multilingual, multiethnic health system, local psychometric testing helps preserve the link between the score and the patient’s lived experience.
The repository also helps prevent duplicated effort. Investigators designing new studies can now identify whether a suitable Singapore-validated tool already exists before starting fresh validation work. Clinicians can also use the repository to support routine care pathways in which symptom burden, function, and quality of life are tracked over time. For health services research, the repository offers a more stable foundation for comparing outcomes across specialties and over time.
There is a bedside consequence here as well. When a PROM is locally validated, a change in score is more defensible as a real change in health status rather than a measurement artifact. That distinction affects treatment decisions, follow-up intensity, and the interpretation of patient progress after an intervention.
Where the Evidence Remains Thin
The distribution across conditions was uneven, and the gaps are as informative as the concentrations. Musculoskeletal disease appears well represented, while several common or clinically important conditions remain without validated local tools. Those missing areas mark where the next validation studies may have the highest practical yield, especially if health systems want PROMs to inform quality improvement, perioperative recovery, or disease-specific follow-up.
The repository does not solve the next problem on its own: implementation. Selecting the right PROM, integrating it into workflow, and interpreting scores consistently across services will require further operational work. Still, the review provides the essential starting point by clarifying what has already been validated in Singapore and where the evidence base remains incomplete.
For clinicians and researchers, the message is direct. Singapore now has a structured catalogue of 115 validated PROMs, but important clinical domains still lack local instruments, and the absence will continue to limit measurement quality until those gaps are filled.